SARSNTdb database: Factors affecting SARS-CoV-2 sequence conservation

IF 2 Q4 VIROLOGY Frontiers in virology Pub Date : 2022-12-01 DOI:10.3389/fviro.2022.1028335
John J Orgera, James J. Kelley, Omri Bar, Sathyanarayanan Vaidhyanathan, A. Grigoriev
{"title":"SARSNTdb database: Factors affecting SARS-CoV-2 sequence conservation","authors":"John J Orgera, James J. Kelley, Omri Bar, Sathyanarayanan Vaidhyanathan, A. Grigoriev","doi":"10.3389/fviro.2022.1028335","DOIUrl":null,"url":null,"abstract":"SARSNTdb offers a curated, nucleotide-centric database for users of varying levels of SARS-CoV-2 knowledge. Its user-friendly interface enables querying coding regions and coordinate intervals to find out the various functional and selective constraints that act upon the corresponding nucleotides and amino acids. Users can easily obtain information about viral genes and proteins, functional domains, repeats, secondary structure formation, intragenomic interactions, and mutation prevalence. Currently, many databases are focused on the phylogeny and amino acid substitutions, mainly in the spike protein. We took a novel, more nucleotide-focused approach as RNA does more than just code for proteins and many insights can be gleaned from its study. For example, RNA-targeted drug therapies for SARS-CoV-2 are currently being developed and it is essential to understand the features only visible at that level. This database enables the user to identify regions that are more prone to forming secondary structures that drugs can target. SARSNTdb also provides illustrative mutation data from a subset of ~25,000 patient samples with a reliable read coverage across the whole genome (from different locations and time points in the pandemic. Finally, the database allows for comparing SARS-CoV-2 and SARS-CoV domains and sequences. SARSNTdb can serve the research community by being a curated repository for information that gives a jump start to analyze a mutation’s effect far beyond just determining synonymous/non-synonymous substitutions in protein sequences.","PeriodicalId":73114,"journal":{"name":"Frontiers in virology","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in virology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fviro.2022.1028335","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

SARSNTdb offers a curated, nucleotide-centric database for users of varying levels of SARS-CoV-2 knowledge. Its user-friendly interface enables querying coding regions and coordinate intervals to find out the various functional and selective constraints that act upon the corresponding nucleotides and amino acids. Users can easily obtain information about viral genes and proteins, functional domains, repeats, secondary structure formation, intragenomic interactions, and mutation prevalence. Currently, many databases are focused on the phylogeny and amino acid substitutions, mainly in the spike protein. We took a novel, more nucleotide-focused approach as RNA does more than just code for proteins and many insights can be gleaned from its study. For example, RNA-targeted drug therapies for SARS-CoV-2 are currently being developed and it is essential to understand the features only visible at that level. This database enables the user to identify regions that are more prone to forming secondary structures that drugs can target. SARSNTdb also provides illustrative mutation data from a subset of ~25,000 patient samples with a reliable read coverage across the whole genome (from different locations and time points in the pandemic. Finally, the database allows for comparing SARS-CoV-2 and SARS-CoV domains and sequences. SARSNTdb can serve the research community by being a curated repository for information that gives a jump start to analyze a mutation’s effect far beyond just determining synonymous/non-synonymous substitutions in protein sequences.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
SARSNTdb数据库:影响SARS-CoV-2序列保守的因素
SARSNTdb为具有不同程度严重急性呼吸系统综合征冠状病毒2型知识的用户提供了一个精心策划的以核苷酸为中心的数据库。其用户友好的界面允许查询编码区域和坐标区间,以找出作用于相应核苷酸和氨基酸的各种功能和选择性约束。用户可以轻松获得有关病毒基因和蛋白质、功能域、重复序列、二级结构形成、基因组内相互作用和突变流行率的信息。目前,许多数据库都集中在系统发育和氨基酸取代方面,主要是在刺突蛋白中。我们采取了一种新的、更注重核苷酸的方法,因为RNA不仅仅是编码蛋白质,而且可以从它的研究中获得许多见解。例如,目前正在开发针对严重急性呼吸系统综合征冠状病毒2型的RNA靶向药物疗法,了解仅在该水平上可见的特征至关重要。该数据库使用户能够识别更容易形成药物可以靶向的二级结构的区域。SARSNTdb还提供了来自约25000个患者样本子集的说明性突变数据,该数据在整个基因组中具有可靠的读取覆盖率(来自疫情中的不同地点和时间点。最后,该数据库可以比较严重急性呼吸系统综合征冠状病毒2型和严重急性呼吸综合征冠状病毒结构域和序列。严重急性呼吸系综合征冠状病毒数据库可以为研究界服务,它是一个精心策划的信息库,可以为分析突变的影响提供一个跳跃式的起点,而不仅仅是确定蛋白质序列中的同义/非同义取代。)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Frontiers | Phylogenetic-based methods for fine-scale classification of PRRSV-2 ORF5 sequences: a comparison of their robustness and reproducibility Frontiers | A proposed new Tombusviridae genus featuring extremely long 5' untranslated regions and a luteo/polerovirus-like gene block Frontiers | Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in non-vaccinated People Living with HIV in Uganda during the year 2022 Frontiers | Predicting Antibody and ACE2 Affinity for SARS-CoV-2 BA.2.86 and JN.1 with In Silico Protein Modeling and Docking Frontiers | HIV latency potential may beis influenced by intra-subtype genetic differences in the viral long-terminal repeat
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1